Aurora Cannabis (ACB) Cash from Restructuring (2018 - 2022)
Aurora Cannabis (ACB) posted quarterly Cash from Restructuring of $2.1 million for Q2 2022, up 753.76% quarter-over-quarter from -$327647.8 in Q4 2021.
Aurora Cannabis (ACB) Cash from Restructuring (2018 - 2022) Analysis & Trends
Aurora Cannabis (ACB) has reported Cash from Restructuring for 4 consecutive years, with $2.1 million the latest figure, recorded in Q2 2022.
- In Q2 2022, Cash from Restructuring changed N/A year-over-year to $2.1 million; the TTM figure through Jun 2022 stood at $2.5 million (changed N/A YoY), while the FY2022 annual figure was $2.2 million, changed N/A from the prior year.
- Cash from Restructuring rose to $2.1 million in Q2 2022 per ACB's latest filing, from -$327647.8 in the prior quarter.
- Across five years, Cash from Restructuring topped out at $2.1 million in Q2 2022 and bottomed at -$327647.8 in Q4 2021.
- Historically, Cash from Restructuring has averaged $1.1 million across 4 years, with a median of $1.5 million in 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 2.14 Mn |
| Dec 31, 2021 | -327,647.80 |
| Sep 30, 2021 | 645,854.77 |
| Mar 31, 2019 | 1.51 Mn |
| Sep 30, 2018 | 1.71 Mn |